Ian J Martins
Nobel Research Award 2024 (Scientific Laurels) Eminent Scientist Award (INSO 2023), Excellence Service Award (INSO 2023), Outstanding Scientist Award 2022, (INSO AWARDS), International Scientist Lifetime Achievement Award 2022 (INSO AWARDS), Life Journey and career: Video Program: Live platform: https://youtu.be/cYy4OmTkKvY?t=21, Distinguished Scientist Award in "International Scientist Awards on Engineeering, Science and Medicine", (2021), Dr Martins is now in the top 30 INTERNATIONAL FELLOWS of history (https://sites.google.com/site/internationalindexing/advisory-board). Dr Martins is a WORLD CHAMPION and has World Records to his credit in Endocrinology & Metabolism, Diabetes and Nutrition, Dr.Med, DSc (Honoris Causa) Doctrin De Science Award Honoris Causa), Top Scholar (Scholar GPS, 0.5%), AD Scientific Index Rankings for Scientist, 139201 from 1037828. Editor/Reveiwer for Open Acess Pub/MDPI and Scientific Reports (Nature) journals and other journals. Dr Martins has reveiwed approx. 4000 INVITED articles over past 5 years. Advisory Board Member for Photon Journal. Chief Editor for Biomedical and Pharmacology, Chief Editor for Journal of Neuroscience and Neurological Surgery, Chief Editor for International Journal of Diabetes Research (2014-2021), Research and Reviews: Neuroscience(2016-2021) and Journal of Diabetes and Clinical Studies (2017-2021),Advancement in Case Studies (2020-2023), American Journal of Biomedical Science and Research (2023), Global Journal of Endocrinology and Metabolism (2020-2023), Interventions in Obesity and Diabetes (2020-2023), Journal of Spine and Neuroscience, Innovations in Molecular Biotechnology, Journal of Metabolic Syndrome and Journal of Diabetes, Obesity and Metabolism. BIT Member (BIT Congress. Inc) with an h-index of >185. Google Scholar (37),ResearchGate (37) with RESEARCH INTEREST SCORE in Nutrition and Dietetics (> 97 %) of all RESEARCHGATE MEMBERS > 2260, > 62092 reads, 76 mentions, >309 Recommendations. Scopus Mendeley (26), UWA Research Repository (19), Semantic Scholar (33), Publon, Web of Science Researcher ID AAC-3215-2020 (1) Top Peer Reveiwer, 446 verified reveiws and 92 editor reveiws. Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu (>10400 veiws, >2000 public mentions) 1-5% CUP. Postdoctoral Researcher Frontiers in Genetics (10,746 veiws/downloads, 1527 citations),Dimensions (1909 citations),AD Scientific Index Ranking (>4880 citations (H=37), Scholar GPS (32) . The citations past 25 years >29,000. Editorial Board Member for 150 journals. Semantic Scholar profile with 133 highly influential citations from 204 PUBLICATIONS, ECU RESEARCH ONLINE (>7642) downloads across 51 papers). Scientific Research Publishing articles (46445 downloads, 72450 veiws, 294 citations). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). 904 INTERNATIONAL Certificates from conferences, congresses, summits and journals. Keynote addresses at International Conference on Biomedicine and Pharmacotherapy 2018, Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome 2018, Immunology World 2018, Laboratory Medicine 2018, Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016. Chair Sessions on International Conference on Biomedicine and Pharmacotherapy 2018, Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome 2018, Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine, 13th Interantional Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethanopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Reveiwer/Editor 200 journals. > 700 IMPORTANT PUBLICATION ACHIEVEMENTS TWEET:Twitter https://twitter.com/IanJamesMartin2.
Invited Organizing committee member for 200 conferences around the world (2020-2024)
BLOOD TEST critical to COVID-19, diabetes and neurodegenerative disease.
Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions. ECPT 6.4 (2018): 209-215.
The Scientific News, Advances in Treating Diseases. November Edition, 2018. Annie B. Coulter, REFERENCE: Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease. Non Alcoholic Fatty Liver Disease. An Update. IntechOpen, 2018.
Supervisors: ADVISORS
Phone: 0863042574
Address: Centre of Excellence in Alzheimer's Disease Research and Care,
School of Medical and Health Sciences,
Edith Cowan University.
270 Joonndalup Drive,
Joondalup, Perth, Western Australia,
Australia
Invited Organizing committee member for 200 conferences around the world (2020-2024)
BLOOD TEST critical to COVID-19, diabetes and neurodegenerative disease.
Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions. ECPT 6.4 (2018): 209-215.
The Scientific News, Advances in Treating Diseases. November Edition, 2018. Annie B. Coulter, REFERENCE: Insulin Therapy and Autoimmune Disease with Relevance to Nonalcoholic Fatty Liver Disease. Non Alcoholic Fatty Liver Disease. An Update. IntechOpen, 2018.
Supervisors: ADVISORS
Phone: 0863042574
Address: Centre of Excellence in Alzheimer's Disease Research and Care,
School of Medical and Health Sciences,
Edith Cowan University.
270 Joonndalup Drive,
Joondalup, Perth, Western Australia,
Australia
less
InterestsView All (21)
Uploads
Papers by Ian J Martins
ONLINE REFERENCES:
Nutrition Therapy Regulates Caffeine Metabolism with Relevance to NAFLD and Induction of Type 3 Diabetes. J Diabetes Metab Disord 2017, 4: 019. Published: April 03, 2017 PAGES 1-9.
Caffeine Consumption and Induction of Obesity in the Developed World. Ann Obes Disord. 2017; 2(1): 1018.
Caffeine consumption with Relevance to Type 3 diabetes and accelerated brain aging. Research and Reveiws: Neuroscience. 1,1, December, 2016.
Food intake and caffeine determine amyloid beta metabolism with relevance to mitophagy in brain aging and chronic disease. European Journal of Food Science and Technology. 2016;4:11-17.
REFERENCE: Martins IJ Food intake and caffeine determine amyloid beta metabolism with relevance to mitophagy in brain aging and chronic disease European Journal of Food Science and Technology Vol.4, No.5, pp. 11-17, December 2016
REFERENCES:
1. Martins IJ. Diabetes and Organ Dysfunction in the Developing and Developed. World Global Journal of Medical Research: F Diseases Volume 15 Issue 1 Version 1.0 Year 2015.
2. Martins IJ. (2015) Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases. Int J Mol Sci. 2015.6(12): 29554–29573.
3. Martins IJ. Early diagnosis of neuron mitochondrial dysfunction may reverse global metabolic and neurodegenerative disease. Global Journal of Medical Research.. 2016;2: 1-8.
4. Martins IJ. Bacterial Lipopolysaccharides Change Membrane Fluidity with Relevance to Phospholipid and Amyloid Beta Dynamics in Alzheimer’s Disease. J Microb Biochem Technol, 2016, 8: 322-324.
5. Martins IJ. The Future of Genomic Medicine Involves the Maintenance of Sirtuin 1 in Global Populations. Int J Mol Biol. 2017; 2(1):1-4.
6. Martins I J. Unhealthy Diets Determine Benign or Toxic Amyloid Beta States and Promote Brain Amyloid Beta Aggregation. Austin J Clin Neurol 2015;2(7): 1060-66.
7. Martins IJ. LPS Regulates Apolipoprotein E and Aβ Interactions with Effects on Acute Phase Proteins and Amyloidosis. Advances in Aging Research 03/2015; 4(2):69-77.
8. Martins, IJ.The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease. Proteomes, 2016. 4(2) 1-19.
9. Martins IJ. Bacterial LPS overrides Adenosine treatment of Epileptic Seizures. EC Microbiology. 2017. In Press.
RELEVANT REFERENCS
Martins IJ. Type 3 diabetes with links to NAFLD and Other Chronic Disease in the Western World. International Journal of Diabetes. 2016; 1:1-5.
Martins IJ. Diet and Nutrition reverse Type 3 Diabetes and Accelerated Aging linked to Global chronic diseases. J Diab Res Ther. 2016; 2(2).
Martins IJ. Magnesium Therapy Prevents Senescence with the Reversal of Diabetes and Alzheimer’s Disease. Health, 2016, 8, 694-710.
Martins, I.J. Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Advances in Aging Research, 2016, 5, 9-26
Martins IJ. Diabetes and Organ Dysfunction in the Developing and Developed. World Global Journal of Medical Research: F Diseases Volume 15 Issue 1 Version 1.0 Year 2015. CERTIFICATE OF PUBLICATION.
Nutritional and Genotoxic Stress Contributes to Diabetes and Neurodegenerative Diseases such as Parkinson's and Alzheimer's Diseases. - Frontiers in Clinical Drug Research -CNS and Neurological Disorders. Volume 3 Editor: Atta-ur-Rahman Pp. 158-192 (35) DOI: ON LINE CHAPTER/EBOOK: 2015
lipidmetabolismmay be a consequence of the disease process, or part of the pathogenic mechanism, or both. More importantly perhaps, with respect to AD, is the mounting evidence that dyslipidaemia helps to drive production or reduce clearance of Aβ, the amyloidogenic peptide believed to be central in AD pathogenesis. Furthermore, other
dyslipidaemia-related conditions have also been linked to AD pathogenesis, including obesity, hypertension, inflammation, insulin resistance, and type 2 diabetes. Apart from advancing age, the carriage of one or two copies of the APOE 𝜀4 alleles is one of the
biggest risk factors for developing late-onset (sporadic) AD. The product of this gene is apoE, a protein involved in the transport of lipids. Possession of APOE 𝜀4 alleles also predisposes individuals to a higher risk of cardiovascular disease. Here we discuss lipid
and cholesterol metabolism, and we give an overview of the various lipid and cholesterol metabolic pathways and changes that have been linked toAD, particularly the influence of the different forms of apoE on lipid, cholesterol, and Aβ metabolism.
The market for vaccines is expected to reach 50 billion dollars by the year 2020. The development process for vaccine development from research to marketing may take 10 years and cost approx 1 billion dollars but the success rate of vaccine development may be very low. Critical interest in research to maintain vaccines that enhance the immune response to prevent diseases has been the focus of vaccine development. WHO funded vaccine preventable conditions and disease projects may only be successful with effective low calorie nutrigenomic diets that activate anti-aging gene expression critical to maintain the primary and secondary immune response in man and other species. In the developing world increasing therapeutic anti-aging protein levels in the plasma and cells has become important to maintain the immune system with relevance to vaccine technology. Biotherapy, core body temperature and anti-aging gene activation with relevance to the chronic disease epidemic is critical to prevent mitophagy and autoimmune disease linked to the prevention of inactivation of vaccines and vaccine development. Articles for this special issue are required to assess the role of anti-aging genes and activation of the transcriptional co-activator relevant to the adaptive immune response that determines the success of old and new vaccine development.
https://www.mdpi.com/journal/vaccines/special_issues/technology_vaccines
KEY WORDS: Genomic medicine, vaccine development, diet , anti-aging genes, transcriptional regulator, autoimmune disease developing world, immune response, anti-aging protein, biotherapy, species
We are well aware that the diabetes epidemic is now expected to become a global pandemic by the year 2050. The data shows that nearly 592 million people succumb to the disease in both the developing and developed nations. Medical scientists have been trying to find a solution to treat this disease. ...........................